Torrent Pharmaceuticals has finalized the acquisition of 7,44,81,519 equity shares of JB Chemicals, representing 46.39% of its equity share capital. This acquisition, completed on January 21, 2026, involved purchasing shares from Tau Investment Holdings Pte. Ltd. Following the acquisition, Torrent Pharmaceuticals now holds a total of 7,44,82,836 equity shares in JB Chemicals and has been classified as a ‘promoter.’
Equity Stake Acquisition
Torrent Pharmaceuticals has completed the acquisition of equity shares in JB Chemicals & Pharmaceuticals Limited. The transaction finalized on January 21, 2026. This acquisition enhances Torrent Pharmaceuticals’ position in the market.
Details of the Acquisition
The company successfully acquired 7,44,81,519 equity shares of JB Chemicals, representing 46.39% of the equity share capital on a fully diluted basis. These shares were acquired from Tau Investment Holdings Pte. Ltd. as part of a share purchase agreement initially dated June 29, 2025.
Post-Acquisition Holdings
Following this acquisition, and including additional shares acquired through an open offer, Torrent Pharmaceuticals now holds an aggregate of 7,44,82,836 equity shares of JB Chemicals. This represents 46.39% of the equity share capital of JB Chemicals on a fully diluted basis. Torrent Pharmaceuticals has been classified as a ‘promoter’ of JB Chemicals, effective January 21, 2026.
Source: BSE
